Susquehanna Fundamental Investments’s Mereo BioPharma MREO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$192K	Sell	171,600 -5,700	-3%	-$7.37K	﹤0.01%	1377
2021 Q4	$284K	Sell	177,300 -8,200	-4%	-$16.4K	0.01%	1133
2021 Q3	$449K	Buy	185,500 +127,300	+219%	+$337K	0.01%	1256
2021 Q2	$184K	Buy	58,200 +45,000	+341%	+$151K	﹤0.01%	1504
2021 Q1	$44K	Buy	13,200 +2,000	+18%	+$7.07K	﹤0.01%	1501
2020 Q4	$40K	Buy	+11,200	New	+$28.1K	﹤0.01%	1458

Other funds holding MREO

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Susquehanna Fundamental Investments's MREO Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its Mereo BioPharma (MREO) stake by 3.2% in Q1 2022, selling an estimated $7.37K and leaving 171,600 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #1377.

Susquehanna Fundamental Investments first reported a position in MREO in Q4 2020 and has held it in 6 quarters since. The position peaked at $449K in Q3 2021. 60 funds tracked by Wall St. Rank hold MREO as of Q1 2022.

Susquehanna Fundamental Investments held 171,600 shares of Mereo BioPharma worth $192K as of Q1 2022.
Susquehanna Fundamental Investments sold 5,700 Mereo BioPharma shares in Q1 2022, an estimated $7.37K.
Mereo BioPharma made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1377 holding.
Susquehanna Fundamental Investments first reported a position in Mereo BioPharma in Q4 2020 and has held it in 6 quarters since.
Susquehanna Fundamental Investments's Mereo BioPharma position peaked at $449K in Q3 2021.
60 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.